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ABSTRACT 31 
AIM: To apply topographical mapping of the electromyography (EMG) amplitude recorded from 32 
the upper trapezius muscle to evaluate the distribution of activity and the location of peak activity 33 
during a shoulder elevation task in subjects with and without myofascial pain and trigger points 34 
(MTrP) and compare this location with the site of the MTrP. 35 
METHODS:  Thirteen subjects with myofascial pain and MTrP in the upper trapezius muscle and 36 
12 asymptomatic subjects participated. High-density surface EMG was recorded from the upper 37 
trapezius muscle using a matrix of 64 surface electrodes aligned with an anatomical landmark 38 
system (ALS). Each subject performed a shoulder elevation task consisting of a series of 30 s 39 
ramped contractions to 15% or 60% of their maximal voluntary contraction (MVC) force. 40 
Topographical maps of the EMG average rectified value were computed and the peak EMG 41 
amplitude during the ramped contractions was identified and its location determined with respect to 42 
the ALS. The location of the MTrP was also determined relative to the ALS and Spearman’s 43 
correlation coefficients were used to examine the relationship between MTrP and peak EMG 44 
amplitude location.  45 
RESULTS:  The location of the peak EMG amplitude was significantly (p<0.05) different between 46 
groups (subjects with pain/MTrP: -0.32 ± 1.2 cm at 15% MVC and -0.35 ± 0.9 cm at 60% MVC 47 
relative to the ALS; asymptomatic subjects: 1.0 ± 1.3 cm at 15% MVC and 1.3 ± 1.1 cm relative to 48 
the ALS). However, no correlation was observed between the position of the MTrP and peak EMG 49 
amplitude during the ramped contractions at either force level (15%: rs = .039, p = .9; 60%: rs = - 50 
.087, p = .778). 51 
CONCLUSION: People with myofascial pain and MTrP displayed a caudal shift of the distribution 52 
of upper trapezius muscle activity compared to asymptomatic individuals during a submaximal 53 
shoulder elevation task.  However, for the first time, we show that the location of peak muscle 54 
activity is not associated with the location of MTrP. 55 
 56 
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INTRODUCTION 57 
 Myofascial trigger points (MTrP) are considered to be a common cause of primary or 58 
secondary muscle pain. Local or referred pain elicited by active MTrP can contribute to pain 59 
symptoms in people with several different musculoskeletal conditions [1-5]. Although several 60 
factors, such as muscle trauma, repetitive low-intensity muscle overload, intense muscle 61 
contraction, or psychological stress, have been suggested to play an important role in the activation 62 
of MTrP, the etiology remains speculative [6-8]. 63 
 Hubbard and Berkoff conducted the first needle electromyography (EMG) investigation of 64 
MTrP in the upper trapezius muscle and described two abnormal patterns; a low amplitude 65 
persistent activity of 50 μV and intermittent higher amplitude spike-like activity of 100-700 μV [9]. 66 
Such spontaneous and persistent background EMG activity of the MTrP were supported by further 67 
investigations [10-13]. However, the origin of such activity has been debated. Possible explanations 68 
include dysfunctional endplates located nearby the MTrP [14-16]. 69 
 More recently, Chung et al measured EMG from seven subjects with MTrP in the trapezius 70 
muscle. Needle EMG was recorded from the tender area and control sites at various depths for a 71 
prolonged time. All subjects exhibited a reliable resting EMG signal identified at subject-specific 72 
depths which were not associated with general muscle activation [17]. The atypical electrical 73 
activity was interpreted as motor unit action potentials and their prevalence closely correlated with 74 
the pressure pain threshold of the MTrP [13]. Furthermore, a study evaluating people with latent 75 
MTrP in the upper trapezius muscle documented early myoelectric manifestations of fatigue of the 76 
upper trapezius during sustained isometric contractions, and notably the muscle fibers close to the 77 
latent MTrP exhibited an anticipated and significant increase in surface EMG amplitude [18].  An 78 
increase of the intramuscular EMG amplitude of the trapezius muscle has also been observed in 79 
subjects with latent MTrP during synergistic muscle activation [19]. 80 
 Based on these observations, it may be expected that the distribution of activity of the upper 81 
trapezius muscle would be different in people with MTrP and that the location of the peak activity 82 
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may even be located at the site of the MTrP. However, until now, methodological limitations have 83 
prevented this investigation. 84 
 High-density, two-dimensional surface EMG provides a measure of the electric potential 85 
distribution over a large surface area during muscle contraction [20-22].  Unlike classic bipolar 86 
EMG applications, this method provides a topographical representation of EMG amplitude, and can 87 
identify the intensity of activity within regions of a muscle and the location of the peak EMG 88 
amplitude across a large region of the muscle. High-density EMG studies have confirmed that either 89 
acute experimental muscle pain [23] or chronic clinical pain [24, 25] may alter the distribution of 90 
muscle activity and may cause a shift of the peak muscle activity. Considering these findings, it 91 
may be speculated that a long-lasting nociceptive irritant, such as a MTrP, could induce a spatial 92 
reorganization of muscle activity however this has never been evaluated.   93 
 In this study we extracted topographical maps of the upper trapezius surface EMG amplitude 94 
to evaluate the distribution of muscle activity and the location of peak activity during a submaximal 95 
shoulder elevation task in subjects with and without myofascial pain and MTrP within the upper 96 
trapezius muscle. For the first time, we examined the relationship between the location of the MTrP 97 
spot tenderness and the location of the peak EMG amplitude. We hypothesized that the distribution 98 
of upper trapezius muscle activity and therefore the location of the peak activity during a shoulder 99 
elevation task would be different in people with MTrP compared to those without and that the 100 
location of the peak may correspond to the location of the spot tenderness.  101 
 102 
METHODS 103 
 Experimental sessions were conducted between May and June 2012 in the Laboratory of 104 
Movement Analysis at Vita-Salute San Raffaele University, Milan, Italy. The study was approved 105 
by the Internal Ethics Committee and conducted in accordance with the Declaration of Helsinki. All 106 
participants signed an informed consent form before enrolling in the study.  107 
 108 
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Participants 109 
 A convenience sample of twelve asymptomatic subjects (seven men; age, mean±SD: 21.8 ± 110 
1.4 years) and 13 (six men; age: 22.8 ± 3.5 years) individuals with myofascial pain and the 111 
presences of at least one MTrP in right upper trapezius muscle participated in the study following 112 
advertisement at the Vita-Salute San Raffaele University. The inclusion criteria for asymptomatic 113 
subjects were no sign or symptom of musculoskeletal pain in the cervical region, thoracic region 114 
and upper limb, and the absence of a clinically relevant MTrP in the right upper trapezius muscle. 115 
The inclusion criteria for the symptomatic group was at least one clinically relevant MTrP [26] in 116 
the right upper trapezius muscle and reported pain over the upper trapezius muscle in the last 2 117 
weeks. All subjects in both groups were right hand dominant. The exclusion criteria for both groups 118 
were: history of neurological or rheumatic disorders, cervical radiculopathy or radicular pain in the 119 
previous 6 months, whiplash injury in the previous 6 months, the presence of mental or emotional 120 
disorders, the presence of scars or moles in the area of the upper trapezius muscle, pregnancy, and a 121 
body mass index of 30 or higher. 122 
 The clinical examination to detect the presence of MTrP was performed by an expert 123 
physiotherapist with more than 10 years of experience in the diagnosis and management of 124 
myofascial pain syndromes. Diagnostic criteria for a clinically relevant MTrP were: the presence of 125 
a palpable taut band, the presence of spot tenderness within the taut band, and the elicitation by 126 
manual palpation of either one or a combination between pain recognition and referred pain [26]. 127 
Pain recognition was defined as the reproduction of a familiar pain by manual compression of the 128 
MTrP spot tenderness. If more than one MTrP was detected, the MTrP which elicited a familiar 129 
pain was considered. If the subject was not able to distinguish between two MTrPs and they 130 
reported familiar pain at both sites, the examiner asked the subject to identify the most painful 131 
MTrP on palpation. 132 
 133 
 134 
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Procedure  135 
 The subject was seated with their back supported, knees and hips flexed to 90°and their arms 136 
by their side in a relaxed position. An operator marked a standardized anatomical landmark system 137 
(ALS) over the right shoulder region of all subjects while they were seated [27]. The ALS consisted 138 
of a line between the spinous process of the seventh cervical vertebrae and the acromial angle (X-139 
axis), and a second line perpendicular to the first passing through its midpoint (Y-axis). The 140 
distance between the spinous process of the seventh cervical vertebrae and the acromial angle was 141 
measured using a measuring tape. 142 
 A palpation examination was performed on all subjects.  For the subjects with myofascial 143 
pain, the examination was performed to confirm the presence of a clinically relevant MTrP, while 144 
for asymptomatic subjects it was performed to exclude the presence of any MTrP and specifically 145 
any spot tenderness within any taut band of the upper trapezius muscle.  For the subjects with 146 
myofascial pain and MTrP, the examiner marked the location of the MTrP on the skin using a 147 
custom designed stamp (1 cm2 circle with a dot in the centre). The dot in the centre was overlapped 148 
with the spot tenderness, and its distance from the X- and Y-axes of the ALS was measured with a 149 
measuring tape.  Pain pressure threshold (PTT) over the spot tenderness was recorded using an 150 
algometer (Wagner Instruments, Greenwich, CT, USA). The contact area of the algometer tip was 1 151 
cm2 and the application rate was approximately 1 kg/s. PPT was measured three times over 10 s 152 
intervals, and the average value was recorded as the PPT. 153 
 Two adjustable straps connected to the load cells were positioned over the acromion of both 154 
shoulders (Figure 1). The subject was instructed to keep their trunk against the back of the chair and 155 
both the straps were tensioned to avoid any shoulder movements.  The subject was then instructed 156 
to perform a shoulder elevation task that consisted of pushing up both shoulders towards the ceiling. 157 
Two maximal voluntary contractions (MVCs) of shoulder elevation were performed, each lasting 158 
~4 sec with 2 min rest in between. The subjects were asked to reach their maximum force gradually 159 
and were verbally motivated by the investigator. For each of the two MVC contractions, the average 160 
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value around the maximum force was considered and the highest of the two values was taken as the 161 
reference MVC. After ~2 min of rest the subject performed a series of 6 ramped contractions from 162 
0-15-0% and 0-60-0% MVC each of 60 sec duration. The order of the ramp contractions was 163 
alternated (15%, 60%, 15%, 60%, 15%, 60%). Visual feedback was provided by means of a moving 164 
arrow and two moving bars on a screen positioned ~1 m in front of the subject. EMG and force 165 
signals were acquired during each contraction. 166 
 167 
Electromyography 168 
 Surface EMG was detected in a monopolar referenced configuration with a semidisposable 169 
adhesive grid of electrodes (model ELSCH064, OT-Bioelettronica, Torino, Italy). The grid 170 
consisted of 13 rows and 5 columns of electrodes with one electrode absent at the lower left corner. 171 
The diameter of each electrode is 2 mm and the inter-electrode distance 8 mm in both directions.  172 
 Firstly, the innervation zone of the upper trapezius was identified using a linear electrode 173 
array and the electrode grid was then positioned medial to this point, with the fourth row along the 174 
X-axis of the ALS (Figure 2). The rows of the electrode grid were positioned parallel to the line 175 
between C7 and the acromion. The grid was fixed to the skin with double adhesive tape following 176 
skin preparation by gentle local abrasion with abrasive paste and cleansing with water.  The 177 
electrode cavities were filled with conductive paste to ensure a proper electrode-skin contact.  178 
 The EMG signals were amplified (EMG-USB2 amplifier, OT-Bioelettronica, Torino, Italy), 179 
sampled at 2048 Hz and stored on a PC after 16 bit A/D conversion. A reference electrode was 180 
placed around the right wrist. 181 
 182 
Force 183 
 Shoulder elevation force was measured with two load cells that operated linearly in the 184 
range 0–1000 N (Mod. TF2/S, CCT Transducers, Torino, Italy). The load cells, fixed on a wooden 185 
plate on the ground, were secured over the subject’s shoulders (over the acromion) with two 186 
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adjustable straps. The force signals were amplified (MISO-II, OT-Bioelettronica, Torino, Italy, 187 
bandwidth 0–80 Hz) and stored on a PC (sampling rate 2048 Hz; 12 bit A/D converter). The force 188 
signal was presented as visual feedback to the subjects during the shoulder elevation tasks. 189 
 190 
Signal processing 191 
For each of the two force levels, the force and EMG signals of the three ramp contractions 192 
were visually inspected, and the best of the three (in terms of EMG signal quality and precision of 193 
the force with respect to the target) was selected and used for further analysis. Single differential 194 
(SD) signals were computed for each pair of adjacent electrodes by differentiating the monopolar 195 
signals of the adjacent columns (SD longitudinal along the direction of the muscle fibers). The last 196 
row of channels (13th) was excluded from further analysis because of the absent electrode in the 197 
lower left corner, in order to have a rectangular grid of 12x4 SD channels. The SD signals were 198 
digitally filtered with a 4th order Butterworth noncausal filter (20– 450 Hz) in order to reduce 199 
instrumentation noise and slow transients, and divided in epochs of 1 sec. Average rectified values 200 
(ARV), were computed for each channel and for each epoch. The ARV computed in each channel 201 
were combined to generate a 12x4 topographical map of EMG amplitude (ARV) (Figure 2). The 202 
maps of ARV were computed for each epoch and the maximum value was extracted from each row 203 
of each map, leading to a vertical vector of 12 elements for each epoch. The values for the 60 204 
epochs were stored in a table of 12x60 elements where the rows represented the positions of the 205 
electrode in the Y-axis direction and the columns represented the time instants and displayed as 206 
color images (Figure 3). The peaks of the ARV maps were computed for each time instant and 207 
traced over the images, in order to describe the location of EMG signal amplitude of the upper 208 
trapezius muscle. The distance between EMG peaks and MTrP location was computed in the Y-axis 209 
direction in order to describe the distance between MTrP and the most active muscle fibers of the 210 
upper trapezius, which are assumed to be parallel to the ALS (Figure 4).  211 
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 The error of the force with respect to the target force was computed as the mean of the 212 
absolute difference between the actual force and the requested force profile (equivalent to the ARV 213 
of the error). The error was normalized with respect to the instantaneous target force values and 214 
expressed as a percentage (% TF).  The analysis was performed separately for 15% and 60% ramps 215 
and also for the two portions of the ramps ((up and down slope). The force error provides an 216 
indication of the accuracy of task performance. 217 
 218 
Statistical analysis 219 
 A Shapiro-Wilk test for normality was performed (p <0.05) on all dependent variables and 220 
indicated the need to use non-parametric statistical methods.  Mann-Whitney U test was used to test 221 
for a differences in the accuracy of force between groups and to test for a difference between groups 222 
in EMG amplitude, normalized with respect to the ARV computed during MVC (ARVn), at 223 
different force levels (5-10-15 % MVC or 20-40-60 % MVC ) Friedman test was used to determine 224 
if there were differences in the position of peaks of the EMG signal amplitude during the ramps at 225 
different force levels (5-10-15 % MVC or 20-40-60 % MVC) in both subject groups. Mann-226 
Whitney U test was used to test for a difference in the position of peaks of EMG signal amplitude 227 
during both ramps between groups.   228 
 Descriptive statistics were used to determine the location of the peaks of EMG signal 229 
amplitude according to the ALS, and their distances along the Y-axis from the MTrP location 230 
during both ramp contractions. In the subjects with pain and MTrP, Spearman correlation analysis 231 
was carried out to test whether there was any significant relationship between the location of the 232 
peak of EMG signal amplitude and the MTrP location during both ramp contractions. 233 
Statistical analyses were performed with SPSS Version 22.0 (IBM Corp., Armonk, NY, 234 
USA). Statistical significance was set to α=.05. 235 
 236 
 237 
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RESULTS 238 
Clinical features of the individuals with myofascial pain and MTrP in right upper trapezius 239 
are summarized in Table 1. None of the asymptomatic subjects showed the presence of spot 240 
tenderness within their right upper trapezius. 241 
All subjects completed the submaximal shoulder elevation tasks. The groups were similar at 242 
modulating shoulder elevation force according to the visual feedback during both ramped 243 
contractions, and there was no significant difference in task performance between groups. The force 244 
errors are presented in Table 2 and confirm that both groups were able to perform the task with the 245 
same degree of accuracy. Moreover no significant differences were observed between the force 246 
errors computed in the two portions of the ramps or between the different force levels (15% and 247 
60% MVC). 248 
Values of ARVn obtained during the ramped contractions for both groups are summarized 249 
in Figure 5a and 5b. A significant difference between groups was detected at 15% MVC (p = .046) 250 
and 5% MVC (down slope, p = .040). The position of the peak EMG amplitude did not differ across 251 
the different force levels of the 15% MVC ramped contractions for either group (Friedman’s test: 252 
asymptomatic, p = .644; pain and MTrP; p = .140), whilst it did change significantly across the 253 
different force levels of the 60% MVC ramped contraction for both groups (Friedman’s test: 254 
asymptomatic, p = .008; pain and MTrP; p = .001). The position of the EMG peak amplitude was 255 
significantly different between groups for the ramped contractions at 15% MVC (p = .010), 10% 256 
MVC (down slope, p = .016), 5% MVC (down slope, p = .007), 60% MVC (p = .019) and 40% 257 
MVC (down slope, p = .026) (Figure 5c and 5d).  258 
 The location of the peak EMG amplitude in the participants with pain and MTrP was -0.32 ± 259 
1.2 cm at 15% MVC and -0.35± 0.9 cm at 60% MVC relative to the ALS. In the asymptomatic 260 
subjects, the peak EMG amplitude was 1.0 ± 1.3 cm at 15% MVC and 1.3 ± 1.1 cm at 60% MVC 261 
relative to the ALS. The distance between the peak EMG amplitude and the location of the MTrP 262 
along the Y-axis was 1.51 ± 1.19 cm and 1.34 ± 1.00 cm at 15% and 60% MVC respectively 263 
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(Figure 6). No correlation was observed between MTrP and the peak EMG amplitude position 264 
during the ramped contractions at either force level (15%: rs = .039, p=.9; 60%: rs = -.087, p=.778). 265 
  266 
DISCUSSION 267 
 This study evaluated the topographical distribution of upper trapezius muscle 268 
activation in people with and without myofascial pain and MTrP in the upper trapezius muscle 269 
during a shoulder elevation task.  The results showed that the two groups were similar at 270 
modulating shoulder elevation force according to the visual feedback during both ramped 271 
contractions, and there was no significant difference in task performance between groups. Upper 272 
trapezius EMG amplitude was modulated with force intensity and notably the people with 273 
myofascial pain and MTrP in the upper trapezius muscle showed higher activity, with this 274 
becoming statistically significant at the peak of the 15% MVC ramped contraction and at the end of 275 
down slope of the 15% MVC ramp (i.e. 5% MVC). Importantly, a difference in the location of peak 276 
upper trapezius muscle activity was also noted between groups both at the peaks of the ramps (15% 277 
MVC and 60% MVC) and during the down slope which partially supports our hypothesis. 278 
Specifically, the data showed that the peak EMG amplitude was located at a more caudal location in 279 
the subjects with myofascial pain and MTrP compared to the asymptomatic controls. The MTrP 280 
were located in a well-defined area of the upper trapezius muscle as previously observed [15]. 281 
However, novel to this study, we showed that there was no spatial correlation between the location 282 
of the MTrP and the position of the peak EMG amplitude. MTrPs are typically defined as a 283 
peripheral pain generator that may induce central sensitization. Proposed treatments such as dry 284 
needling and ischemic compression are passive and usually active exercise to address motor control 285 
are not considered. The present results support previous findings of altered muscle activation in 286 
people with myofascial pain during shoulder abduction [28] and provide the basis for future 287 
research on the role of active exercise in the treatment of myofascial pain.  288 
 289 
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The observed change in the peak position during the course of ramped contractions reflects 290 
progressive recruitment or derecruitment of motor units and/or modulation of the discharge rate of 291 
motor units in different locations within the upper trapezius muscle.  Previous work has shown that 292 
the upper trapezius muscle shows non-uniform activation and that not all regions within the upper 293 
trapezius muscle adapt in the same way to load [22, 29, 30], fatigue or pain [31, 32]. Our results 294 
confirm the non-uniform activation of the upper trapezius muscle and, similar to the results 295 
Holtermann and Roeleveld which showed that the activation of the upper trapezius muscle is not 296 
spatially uniform during intense ramp contraction, the current data also showed variation of the 297 
location of the peak EMG amplitude, but only during the 60 % MVC ramped contraction [33]. On 298 
the contrary we did not detect a change in peak EMG amplitude location during the low level force 299 
ramp to 15% MVC probably due the limited force modulation requested during this task.  300 
 The location of peak muscle activity occurred within the upper region of the upper trapezius 301 
muscle where the fascicles act as an agonist for shoulder elevation and facilitate stabilization of the 302 
scapula [34, 35]. However, the region of peak muscle activity was located at a more caudal location 303 
for the subjects with pain MTrP. This observation is in line with previous studies investigating the 304 
effects of experimentally induced muscle pain on the spatial distribution of upper trapezius activity 305 
[23, 36, 37]. Specifically, it has been shown that acute muscle pain induces a caudal shift of the 306 
upper trapezius muscle activity and this occurs regardless of the site of noxious stimulation within 307 
the upper trapezius muscle [23]. Thus the current results provide further evidence of a change in the 308 
spatial distribution of upper trapezius muscle activity in painful conditions. Considering that the 309 
subjects with pain showed higher activity in regions of the muscle which would not normally be as 310 
active, this change in the pattern of muscle activation can be considered as an inefficient motor 311 
strategy which may even perpetuate the painful condition in the long term.  312 
 A main aim of the study was to examine the relationship between the location of the MTrP 313 
and the location of the peak EMG amplitude. The data show that, despite the caudal shift of the 314 
distribution of upper trapezius muscle activity in the subjects with pain, there was no association 315 
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between the location of peak muscle activity and the location of MTrP. Thus we could not confirm 316 
that the muscle fibers close to the MTrP exhibit a significant increase in surface EMG amplitude, as 317 
some previous reports suggest [18]. This is a novel finding which provides new insight into the 318 
association between peak muscle activity and the location of MTrP. We suggest that when the 319 
upper trapezius muscle is painful, the motor adaptation aims preferentially to minimize activation of 320 
the cranial region; possibly because this region has higher pain sensitivity [38].   321 
 322 
Limitations  323 
When considering the reported results, it important to remark that we established the 324 
location of each MTrP using its spot tenderness and by identifying a discrete point according to the 325 
ALS. However, MTrP hyperalgesia, defined using spot tenderness, may not be limited to a discrete 326 
point and may extend through the taut band. We did not collect information regarding the presence 327 
of additional MTrP in the symptomatic group which may be a limitation of the study.  328 
Our symptomatic group were fairly homogenous for most of the clinical features assessed 329 
and only one subject didn’t recognize familiar pain upon palpation of the MTrP. More than half of 330 
the subjects complained of referred pain during the spot tenderness compression.  The MTrP were 331 
located in well-defined area of the upper trapezius muscle as already observed in two recent studies 332 
that adopted the same ALS [15, 27].  Although we did not distinguish between active and latent 333 
MTrP in the current study, all of the symptomatic subjects except for one, respected the criteria for 334 
active MTrP [28] and showed low PPT when compared to both active and latent MTrP recently 335 
observed in two clinical studies [30, 31].  336 
The sample size was small and was not determined a priori. Rather, we recruited subjects 337 
based on convenience sampling and sought to recruit a similar size which was sufficient to show 338 
differences between painful and non-painful conditions in previous high-density EMG studies 339 
[23,24].  Despite being small, the sample size was sufficient in this study to show group differences. 340 
Nevertheless, it important to note that the enrolled subjects were highly selective (i.e. relatively 341 
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young with pressure-sensitive MTrP in the right upper trapezius muscle, as evidenced by their 342 
relatively low PPT). Thus extrapolation of these findings to different populations should be done 343 
with caution.  Moreover, it should also be noted that the subjects included in this study reported 344 
acute pain (onset within the previous two weeks) and different observations may be expected in 345 
people with long-standing symptoms. 346 
The EMG peak position was established during a shoulder elevation task using a 347 
standardized positioning of subjects. But small changes of posture may have occurred during the 348 
contractions which may have affected the peak position of upper trapezius muscle activity. 349 
However, an investigator carefully monitored the subjects’ posture to ensure a consistent starting 350 
posture and performance during the task therefore variations in posture are unlikely to explain the 351 
differences observed between groups. 352 
 The upper trapezius muscle is complex muscle which is activated during many movements 353 
and different tasks. In this study we evaluated peak activity of the upper trapezius muscle during 354 
shoulder elevation since the upper trapezius acts as an agonist during this task. However, 355 
generalization of the results to different movements and tasks should be done with caution. 356 
Moreover, we did not measure resting EMG, which, considering the results of earlier studies, may 357 
have differed between groups.  358 
 359 
CONCLUSION  360 
 During an isometric submaximal shoulder elevation task, the location of peak upper 361 
trapezius muscle activity was located more caudal in people with myofascial pain and MTrP when 362 
compared to asymptomatic individuals indicating a different motor strategy for the task.  This 363 
change in the topographical distribution of muscle activity may have a role in the clinical course of 364 
myofascial pain. However, the location of peak muscle activity was not associated with the specific 365 
location of MTrP. 366 
 367 
  15 
REFERENCES  368 
 369 
1. Bron C, Dommerholt J, Stegenga B, Wensing M and Oostendorp RA. High prevalence of 370 
shoulder girdle muscles with myofascial trigger points in patients with shoulder pain. BMC 371 
musculoskeletal disorders 2011;12:139. 372 
2. Fernandez-Perez AM, Villaverde-Gutierrez C, Mora-Sanchez A, Alonso-Blanco C, Sterling M 373 
and Fernandez-de-Las-Penas C. Muscle trigger points, pressure pain threshold, and cervical range 374 
of motion in patients with high level of disability related to acute whiplash injury. The Journal of 375 
orthopaedic and sports physical therapy 2012;42:634-41. 376 
3. Iglesias-Gonzalez JJ, Munoz-Garcia MT, Rodrigues-de-Souza DP, Alburquerque-Sendin F and 377 
Fernandez-de-Las-Penas C. Myofascial trigger points, pain, disability, and sleep quality in patients 378 
with chronic nonspecific low back pain. Pain medicine 2013;14:1964-70. 379 
4. Munoz-Munoz S, Munoz-Garcia MT, Alburquerque-Sendin F, Arroyo-Morales M and 380 
Fernandez-de-las-Penas C. Myofascial trigger points, pain, disability, and sleep quality in 381 
individuals with mechanical neck pain. Journal of manipulative and physiological therapeutics 382 
2012;35:608-13. 383 
5. Roach S, Sorenson E, Headley B and San Juan JG. Prevalence of myofascial trigger points in the 384 
hip in patellofemoral pain. Archives of physical medicine and rehabilitation 2013;94:522-6. 385 
6. Simons DG. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain 386 
and dysfunction. Journal of electromyography and kinesiology : official journal of the International 387 
Society of Electrophysiological Kinesiology 2004;14:95-107. 388 
7. Quintner JL, Bove GM and Cohen ML. A critical evaluation of the trigger point phenomenon. 389 
Rheumatology 2014. 390 
8. Kuan TS. Current studies on myofascial pain syndrome. Current pain and headache reports 391 
2009;13:365-9. 392 
  16 
9. Hubbard DR and Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. 393 
Spine 1993;18:1803-7. 394 
10. McNulty WH, Gevirtz RN, Hubbard DR and Berkoff GM. Needle electromyographic 395 
evaluation of trigger point response to a psychological stressor. Psychophysiology 1994;31:313-6. 396 
11. Simons DG, Hong CZ and Simons LS. Endplate potentials are common to midfiber myofacial 397 
trigger points. American journal of physical medicine & rehabilitation / Association of Academic 398 
Physiatrists 2002;81:212-22. 399 
12. Chou LW, Hsieh YL, Kao MJ and Hong CZ. Remote influences of acupuncture on the pain 400 
intensity and the amplitude changes of endplate noise in the myofascial trigger point of the upper 401 
trapezius muscle. Archives of physical medicine and rehabilitation 2009;90:905-12. 402 
13. Kuan TS, Hsieh YL, Chen SM, Chen JT, Yen WC and Hong CZ. The myofascial trigger point 403 
region: correlation between the degree of irritability and the prevalence of endplate noise. American 404 
journal of physical medicine & rehabilitation / Association of Academic Physiatrists 2007;86:183-405 
9. 406 
14. Simons DG. Do endplate noise and spikes arise from normal motor endplates? American 407 
journal of physical medicine & rehabilitation / Association of Academic Physiatrists 2001;80:134-408 
40. 409 
15. Barbero M, Cescon C, Tettamanti A, Leggero V, Macmillan F, Coutts F and Gatti R. 410 
Myofascial trigger points and innervation zone locations in upper trapezius muscles. BMC 411 
musculoskeletal disorders 2013;14:179. 412 
16. Gerwin RD, Dommerholt J and Shah JP. An expansion of Simons' integrated hypothesis of 413 
trigger point formation. Current pain and headache reports 2004;8:468-75. 414 
17. Chung JW, Ohrbach R and McCall WD, Jr. Characteristics of electrical activity in trapezius 415 
muscles with myofascial pain. Clinical neurophysiology : official journal of the International 416 
Federation of Clinical Neurophysiology 2006;117:2459-66. 417 
  17 
18. Ge HY, Arendt-Nielsen L and Madeleine P. Accelerated muscle fatigability of latent myofascial 418 
trigger points in humans. Pain medicine 2012;13:957-64. 419 
19. Ge HY, Monterde S, Graven-Nielsen T and Arendt-Nielsen L. Latent myofascial trigger points 420 
are associated with an increased intramuscular electromyographic activity during synergistic muscle 421 
activation. The journal of pain : official journal of the American Pain Society 2014;15:181-7. 422 
20. Barbero M, Merletti R and Rainoldi A. Atlas of muscle innervation zones : understanding 423 
surface electromyography and its applications. Milan ; New York: Springer, 2012. 424 
21. Zwarts MJ and Stegeman DF. Multichannel surface EMG: basic aspects and clinical utility. 425 
Muscle & nerve 2003;28:1-17. 426 
22. Gallina A, Merletti R and Gazzoni M. Uneven spatial distribution of surface EMG: what does it 427 
mean? European journal of applied physiology 2013;113:887-94. 428 
23. Falla D, Arendt-Nielsen L and Farina D. The pain-induced change in relative activation of 429 
upper trapezius muscle regions is independent of the site of noxious stimulation. Clinical 430 
neurophysiology : official journal of the International Federation of Clinical Neurophysiology 431 
2009;120:150-7. 432 
24. Falla D, Andersen H, Danneskiold-Samsoe B, Arendt-Nielsen L and Farina D. Adaptations of 433 
upper trapezius muscle activity during sustained contractions in women with fibromyalgia. Journal 434 
of electromyography and kinesiology : official journal of the International Society of 435 
Electrophysiological Kinesiology 2010;20:457-64. 436 
25. Falla D, Gizzi L, Tschapek M, Erlenwein J and Petzke F. Reduced task-induced variations in 437 
the distribution of activity across back muscle regions in individuals with low back pain. Pain 438 
2014;155:944-53. 439 
26. Myburgh C, Lauridsen HH, Larsen AH and Hartvigsen J. Standardized manual palpation of 440 
myofascial trigger points in relation to neck/shoulder pain; the influence of clinical experience on 441 
inter-examiner reproducibility. Manual therapy 2011;16:136-40. 442 
  18 
27. Barbero M, Bertoli P, Cescon C, Macmillan F, Coutts F and Gatti R. Intra-rater reliability of an 443 
experienced physiotherapist in locating myofascial trigger points in upper trapezius muscle. J Man 444 
Manip Ther 2012;20:171-7. 445 
28 Lucas KR, Rich PA, Polus BI. Muscle activation patterns in the scapular positioning muscles 446 
during loaded scapular plane elevation: the effects of Latent Myofascial Trigger Points. Clin 447 
Biomech (Bristol, Avon) 2010 Oct;25(8):765-70. 448 
 449 
29. Kleine BU, Schumann NP, Stegeman DF and Scholle HC. Surface EMG mapping of the human 450 
trapezius muscle: the topography of monopolar and bipolar surface EMG amplitude and spectrum 451 
parameters at varied forces and in fatigue. Clinical neurophysiology : official journal of the 452 
International Federation of Clinical Neurophysiology 2000;111:686-93. 453 
30. Falla D and Farina D. Periodic increases in force during sustained contraction reduce fatigue 454 
and facilitate spatial redistribution of trapezius muscle activity. Exp Brain Res 2007;182:99-107. 455 
31. Farina D, Leclerc F, Arendt-Nielsen L, Buttelli O and Madeleine P. The change in spatial 456 
distribution of upper trapezius muscle activity is correlated to contraction duration. Journal of 457 
electromyography and kinesiology : official journal of the International Society of 458 
Electrophysiological Kinesiology 2008;18:16-25. 459 
32. Falla D and Farina D. Non-uniform adaptation of motor unit discharge rates during sustained 460 
static contraction of the upper trapezius muscle. Exp Brain Res 2008;191:363-70. 461 
33. Holtermann A and Roeleveld K. EMG amplitude distribution changes over the upper trapezius 462 
muscle are similar in sustained and ramp contractions. Acta Physiol (Oxf) 2006;186:159-68. 463 
34. Johnson G, Bogduk N, Nowitzke A and House D. Anatomy and actions of the trapezius muscle. 464 
Clinical biomechanics 1994;9:44-50. 465 
35. Palmerud G, Sporrong H, Herberts P and Kadefors R. Consequences of trapezius relaxation on 466 
the distribution of shoulder muscle forces: an electromyographic study. Journal of 467 
  19 
electromyography and kinesiology : official journal of the International Society of 468 
Electrophysiological Kinesiology 1998;8:185-93. 469 
36. Madeleine P, Leclerc F, Arendt-Nielsen L, Ravier P and Farina D. Experimental muscle pain 470 
changes the spatial distribution of upper trapezius muscle activity during sustained contraction. 471 
Clinical neurophysiology : official journal of the International Federation of Clinical 472 
Neurophysiology 2006;117:2436-45. 473 
37. Falla D, Arendt-Nielsen L and Farina D. Gender-specific adaptations of upper trapezius muscle 474 
activity to acute nociceptive stimulation. Pain 2008;138:217-25. 475 
38. Binderup AT, Arendt-Nielsen L, Madeleine P. Pressure pain sensitivity maps of the neck-476 
shoulder and the low back regions in men and women. BMC Musculoskelet Disord 2010 Oct 477 
12;11:234. 478 
 479  480 
 481 
TABLE LEGENDS 482 
Table 1. Clinical features of the enrolled individuals with myofascial pain and MTrP in right upper 483 
trapezius. Third to sixth column indicates the positivity for the MTrP criteria, the 7th column 484 
indicates the spot tenderness location according to the ALF, the last column reports the PPT over 485 
the spot tenderness.  486 
 487 
Table 2. Force errors during the ramp contractions computed for the two portions of each ramp (up 488 
and down slope). The error was computed as the mean of the absolute difference between the actual 489 
force with respect to the theoretical force profile requested. The error was normalized with respect 490 
to the instantaneous target force values and expressed as a percentage (% TF). 491 
 492 
FIGURE LEGENDS 493 
  20 
Figure 1. Experimental setup, subjects sat in a chair with their trunk against the chair. Two 494 
adjustable straps, connected to load cells (Mod. TF2/S, CCT Transducers, Torino, Italy) fixed on a 495 
wooden plate, were tensioned over the acromion of both the shoulders. The subject was instructed 496 
to perform a shoulder elevation task that consisted in pushing up both shoulders towards the ceiling. 497 
 An electrode matrix (model ELSCH064, OT-Bioelettronica, Torino, Italy) was placed on the upper 498 
trapezius, and a visual feedback was provided means of a moving arrow and two moving bars on a 499 
screen. 500 
 501 
Figure 2. A) Position of the electrode grid over the right upper trapezius muscle.  The electrode 502 
grid was positioned on the anatomical reference system (ALS), medially to the innervation zone and 503 
with the fourth row along the X-axis. An example of an EMG amplitude map (12x4 elements) of a 504 
single epoch (1 sec.) is superimposed over the electrode grid. B) Example of single differential 505 
EMG signals detected from each row (1 to 12) of the grid is shown. 506 
 507 
Figure 3. Representation of average rectified values (ARV) extracted for the 60 epochs during the 508 
ramp contractions at 15 and 60% MVC recorded from representative subjects: two asymptomatic 509 
subjects (A,C) and two subjects with pain and MTrP in the right upper trapezius (B,D). Black 510 
curves represent the location of the ARV peak along the Y-axis for each time instant. 511 
 512 
Figure 4. Examples of topographical maps of the average rectified value (ARV) detected at the 513 
time instant corresponding to the maximal force value during ramped contractions at 15% and 60% 514 
MVC from representative asymptomatic subjects and subjects with pain and MTrP during ramped 515 
contractions at (A) 15% and (B) 60% MVC. The grey circles represent the location of the MTrP 516 
according to the ALS. 517 
 518 
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Figure 5. Mean (± SD) of the (A,B) normalized average rectified values (ARV) and (C,D) ARV 519 
peak position recorded from asymptomatic subjects and subjects with pain and MTrP during 520 
ramped contractions at 15% and 60% MVC.  * = p<0.05 521 
 522 
Figure 6. Location of the MTrP according to the ALS (grey circles). Blue and red rectangles 523 
represent the distribution (mean and SD) of the EMG amplitude peaks computed at the maximum 524 
value of both ramped contractions at 15% and 60% MVC in the asymptomatic subjects and subjects 525 
with pain and MTrP (blue and red respectively). 526  527 
